NewHydrogen, Inc. reported Q3 2025 results with no revenue and a wider year‑to‑date loss. Net loss was $1,581,894 for the nine months ended September 30, 2025, including a Q3 loss of $482,096. Operating expenses totaled $1,582,324 year to date, driven by higher general and administrative, research and development, and selling and marketing spending.
Cash was $1,306,271 at September 30, 2025, down from $2,104,521 at year‑end, after $1,413,695 used in operations. The company raised $615,445 via its equity financing agreement with GHS, issuing 25,245,680 shares and 803,536 shares for a $30,000 commitment fee. Shareholders’ equity (deficit) was $(2,111,010), and accumulated deficit reached $179,524,441. Working capital was $1,318,162. Management references going‑concern uncertainty but believes current resources support about nine months of operations. As of November 10, 2025, common shares outstanding were 759,218,392. Subsequent to quarter‑end, additional shares were issued to GHS under the financing agreement.